Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome

Giorgio Maria, Giuseppe Brisinda, Anna Rita Bentivoglio, Emanuele Cassetta, Alberto Albanese

Research output: Contribution to journalArticle

Abstract

PURPOSE: Puborectalis syndrome has been difficult to treat. We investigated the efficacy of botulinum toxin in treating patients with puborectalis syndrome who had previously failed to respond to electromyographic biofeedback sessions and who refused to use anal dilators. METHODS: Of a group of 50 patients with chronic outlet obstruction constipation, four patients with puborectalis syndrome were included in the study. The patients were studied using anorectal manometry, defecography, and electromyography and then treated with 30 units of Type A botulinum toxin, injected into two sites on either side of the puborectalis muscle, under ultrasonographic guidance. RESULTS: One patient was lost to follow-up. After treatment in other patients, the frequency of natural bowel movements increased from zero to six per week and laxatives were needed by only one patient. Anorectal manometry demonstrated decreased tone during straining from (mean ± standard deviation) 96.2 ± 12 mmHg to 42.5 ± 13 mmHg at four weeks (P = 0.003) and 63.2 ± 22 mmHg at eight weeks (P = 0.009). Defecography performed eight weeks after treatment showed improvement in the anorectal angle, which increased from 94 ± 11°to 114 ± 13°(P = 0.01), and evacuation of barium paste. Electromyography demonstrated mild paradoxical contraction. However, 16 weeks after treatment one of these three patients suffered symptomatic recurrence. This patient was re-treated with 50 units of toxin; eight months later he required a further 60 units. Seven months after the last injection he reported normal daily bowel movements without the use of laxatives. CONCLUSIONS: Botulinum toxin injection should be considered as a simple therapeutic approach in patients with puborectalis syndrome. The use of higher dosage and a more precise method of toxin injections under transrectal ultrasonography account for the long-term higher success rate. However, because the effects of the toxin wear off within three months of administration, repeated injections could be necessary to maintain the clinical improvement.

Original languageEnglish
Pages (from-to)376-380
Number of pages5
JournalDiseases of the Colon and Rectum
Volume43
Issue number3
Publication statusPublished - Mar 2000

Fingerprint

Botulinum Toxins
Constipation
Defecography
Therapeutics
Laxatives
Injections
Manometry
Electromyography
Type A Botulinum Toxins
Lost to Follow-Up
Barium
Ointments
Ultrasonography
Recurrence
Muscles

Keywords

  • Biofeedback
  • Botulinum toxin
  • Chronic constipation
  • Defecation disorders
  • Outlet Obstruction
  • Puborectalis syndrome

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. / Maria, Giorgio; Brisinda, Giuseppe; Bentivoglio, Anna Rita; Cassetta, Emanuele; Albanese, Alberto.

In: Diseases of the Colon and Rectum, Vol. 43, No. 3, 03.2000, p. 376-380.

Research output: Contribution to journalArticle

Maria, Giorgio ; Brisinda, Giuseppe ; Bentivoglio, Anna Rita ; Cassetta, Emanuele ; Albanese, Alberto. / Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. In: Diseases of the Colon and Rectum. 2000 ; Vol. 43, No. 3. pp. 376-380.
@article{d9c948a3a1504aa89c5de32d3f64001b,
title = "Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome",
abstract = "PURPOSE: Puborectalis syndrome has been difficult to treat. We investigated the efficacy of botulinum toxin in treating patients with puborectalis syndrome who had previously failed to respond to electromyographic biofeedback sessions and who refused to use anal dilators. METHODS: Of a group of 50 patients with chronic outlet obstruction constipation, four patients with puborectalis syndrome were included in the study. The patients were studied using anorectal manometry, defecography, and electromyography and then treated with 30 units of Type A botulinum toxin, injected into two sites on either side of the puborectalis muscle, under ultrasonographic guidance. RESULTS: One patient was lost to follow-up. After treatment in other patients, the frequency of natural bowel movements increased from zero to six per week and laxatives were needed by only one patient. Anorectal manometry demonstrated decreased tone during straining from (mean ± standard deviation) 96.2 ± 12 mmHg to 42.5 ± 13 mmHg at four weeks (P = 0.003) and 63.2 ± 22 mmHg at eight weeks (P = 0.009). Defecography performed eight weeks after treatment showed improvement in the anorectal angle, which increased from 94 ± 11°to 114 ± 13°(P = 0.01), and evacuation of barium paste. Electromyography demonstrated mild paradoxical contraction. However, 16 weeks after treatment one of these three patients suffered symptomatic recurrence. This patient was re-treated with 50 units of toxin; eight months later he required a further 60 units. Seven months after the last injection he reported normal daily bowel movements without the use of laxatives. CONCLUSIONS: Botulinum toxin injection should be considered as a simple therapeutic approach in patients with puborectalis syndrome. The use of higher dosage and a more precise method of toxin injections under transrectal ultrasonography account for the long-term higher success rate. However, because the effects of the toxin wear off within three months of administration, repeated injections could be necessary to maintain the clinical improvement.",
keywords = "Biofeedback, Botulinum toxin, Chronic constipation, Defecation disorders, Outlet Obstruction, Puborectalis syndrome",
author = "Giorgio Maria and Giuseppe Brisinda and Bentivoglio, {Anna Rita} and Emanuele Cassetta and Alberto Albanese",
year = "2000",
month = "3",
language = "English",
volume = "43",
pages = "376--380",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome

AU - Maria, Giorgio

AU - Brisinda, Giuseppe

AU - Bentivoglio, Anna Rita

AU - Cassetta, Emanuele

AU - Albanese, Alberto

PY - 2000/3

Y1 - 2000/3

N2 - PURPOSE: Puborectalis syndrome has been difficult to treat. We investigated the efficacy of botulinum toxin in treating patients with puborectalis syndrome who had previously failed to respond to electromyographic biofeedback sessions and who refused to use anal dilators. METHODS: Of a group of 50 patients with chronic outlet obstruction constipation, four patients with puborectalis syndrome were included in the study. The patients were studied using anorectal manometry, defecography, and electromyography and then treated with 30 units of Type A botulinum toxin, injected into two sites on either side of the puborectalis muscle, under ultrasonographic guidance. RESULTS: One patient was lost to follow-up. After treatment in other patients, the frequency of natural bowel movements increased from zero to six per week and laxatives were needed by only one patient. Anorectal manometry demonstrated decreased tone during straining from (mean ± standard deviation) 96.2 ± 12 mmHg to 42.5 ± 13 mmHg at four weeks (P = 0.003) and 63.2 ± 22 mmHg at eight weeks (P = 0.009). Defecography performed eight weeks after treatment showed improvement in the anorectal angle, which increased from 94 ± 11°to 114 ± 13°(P = 0.01), and evacuation of barium paste. Electromyography demonstrated mild paradoxical contraction. However, 16 weeks after treatment one of these three patients suffered symptomatic recurrence. This patient was re-treated with 50 units of toxin; eight months later he required a further 60 units. Seven months after the last injection he reported normal daily bowel movements without the use of laxatives. CONCLUSIONS: Botulinum toxin injection should be considered as a simple therapeutic approach in patients with puborectalis syndrome. The use of higher dosage and a more precise method of toxin injections under transrectal ultrasonography account for the long-term higher success rate. However, because the effects of the toxin wear off within three months of administration, repeated injections could be necessary to maintain the clinical improvement.

AB - PURPOSE: Puborectalis syndrome has been difficult to treat. We investigated the efficacy of botulinum toxin in treating patients with puborectalis syndrome who had previously failed to respond to electromyographic biofeedback sessions and who refused to use anal dilators. METHODS: Of a group of 50 patients with chronic outlet obstruction constipation, four patients with puborectalis syndrome were included in the study. The patients were studied using anorectal manometry, defecography, and electromyography and then treated with 30 units of Type A botulinum toxin, injected into two sites on either side of the puborectalis muscle, under ultrasonographic guidance. RESULTS: One patient was lost to follow-up. After treatment in other patients, the frequency of natural bowel movements increased from zero to six per week and laxatives were needed by only one patient. Anorectal manometry demonstrated decreased tone during straining from (mean ± standard deviation) 96.2 ± 12 mmHg to 42.5 ± 13 mmHg at four weeks (P = 0.003) and 63.2 ± 22 mmHg at eight weeks (P = 0.009). Defecography performed eight weeks after treatment showed improvement in the anorectal angle, which increased from 94 ± 11°to 114 ± 13°(P = 0.01), and evacuation of barium paste. Electromyography demonstrated mild paradoxical contraction. However, 16 weeks after treatment one of these three patients suffered symptomatic recurrence. This patient was re-treated with 50 units of toxin; eight months later he required a further 60 units. Seven months after the last injection he reported normal daily bowel movements without the use of laxatives. CONCLUSIONS: Botulinum toxin injection should be considered as a simple therapeutic approach in patients with puborectalis syndrome. The use of higher dosage and a more precise method of toxin injections under transrectal ultrasonography account for the long-term higher success rate. However, because the effects of the toxin wear off within three months of administration, repeated injections could be necessary to maintain the clinical improvement.

KW - Biofeedback

KW - Botulinum toxin

KW - Chronic constipation

KW - Defecation disorders

KW - Outlet Obstruction

KW - Puborectalis syndrome

UR - http://www.scopus.com/inward/record.url?scp=0034018827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034018827&partnerID=8YFLogxK

M3 - Article

C2 - 10733120

AN - SCOPUS:0034018827

VL - 43

SP - 376

EP - 380

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 3

ER -